Skip to main content
Figure 4 | Breast Cancer Research

Figure 4

From: Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival

Figure 4

Survival analyses according to the combined results of bone marrow (BM) aspiration performed pretreatment (BM1) and 12 months after start of neoadjuvant treatment (BM3). Kaplan-Meier plots for disease-free survival (DFS), breast cancer specific survival (BCSS) and overall survival (OS) according to the results of the combination of bone marrow disseminated tumor cell (DTC) status at BM1 and BM3.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us